Ancient herbs meet modern dialysis: patch aims to ease pain and depression
NCT ID NCT07380581
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a traditional Chinese medicine patch made from herbs like ginger and Artemisia on 21 dialysis patients who had pain from their fistula. The patch was placed on specific acupoints during dialysis sessions for 4 weeks. Researchers measured pain, depression, and quality of life to see if the patch could help without extra drugs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- herbal patch (Artemisia princeps, ginger, and Draconis Sanguis extract)
- What this could lead to
- If it works, this could offer a simple, drug-free way to manage fistula pain and improve mood for people on dialysis.
- What could go wrong
- This is a very small, early-phase trial (21 people) with no blinding details confirmed, so results may not be reliable or apply to everyone. Herbal patches can sometimes cause skin irritation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
21 people
The number who actually took part.
- Started
-
Feb 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * maintenance HD \> 6 months , * reporting fistula pain during HD sessions that was associated with a hypersensitive palpable nodule in a taut band, at least 6 times in the past month, * a NRS pain score \>4, * no changes in pain relievers such as NSAIDs, opioids, topical ointments, or muscle relaxants over the past week, * voluntarily agreed to participate in the trial and presented written informed consent. Exclusion Criteria: * severe comorbid organ dysfunction, * existence of cervical radiculopathy or thoracic outlet syndrome * inflammation of the skin or soft tissue at the fistula site, * dementia, * psychiatric diseases, * allergy to herbal patch * currently participating in other clinical studies
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End stage chronic renal failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Memorial Hospital in Kaohsiung branch
Kaohsiung City, 83301, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can mindfulness calm the mind and improve sleep for dialysis patients?
- Numbing cream may take the sting out of pelvic pain injections
- A shot of numbing relief: could trigger point injections cut opioid use after neck surgery?
- Ultrasound-Guided fluid removal may offer safer relief for overloaded kidneys
- New ultrasound technique could predict kidney transplant success without needles
- New imaging method could improve pelvic pain treatment